SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-22-076915
Filing Date
2022-07-01
Accepted
2022-07-01 17:24:01
Documents
7

Document Format Files

Seq Description Document Type Size
1 424B3 tm2218232d3_424b3.htm 424B3 129003
2 GRAPHIC tm2218232d1_s3img001.jpg GRAPHIC 24956
3 GRAPHIC tm2218232d1_s3img002.jpg GRAPHIC 35168
4 GRAPHIC tm2218232d1_s3img003.jpg GRAPHIC 23742
5 GRAPHIC tm2218232d1_s3img004.jpg GRAPHIC 53898
6 GRAPHIC tm2218232d1_s3img005.jpg GRAPHIC 31752
7 GRAPHIC tm2218232d3_424b3img005.jpg GRAPHIC 5111
  Complete submission text file 0001104659-22-076915.txt   371596
Mailing Address 201 REDWOOD SHORES PARKWAY, SUITE 315 REDWOOD CITY CA 94065
Business Address 201 REDWOOD SHORES PARKWAY, SUITE 315 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-265703 | Film No.: 221062451
SIC: 2834 Pharmaceutical Preparations